INS and hypertriglyceridemia: • Reduction in hyperglycemia and hypertriglyceridemia (p < 0.05)• Reduced fasting and post-prandial blood glucose levels significantly (p < 0.005 and p < 0.001, respectively)• Significantly increased HbA1c level ( p < 0.001)• Significantly reduced insulin resistance (p< 0.05)